{
    "clinical_study": {
        "@rank": "141298", 
        "arm_group": [
            {
                "arm_group_label": "Budesonide dosage 1", 
                "arm_group_type": "Experimental", 
                "description": "Budesonide 2 mg suppository"
            }, 
            {
                "arm_group_label": "Budesonide dosage 2", 
                "arm_group_type": "Experimental", 
                "description": "Budesonide 4 mg suppository"
            }, 
            {
                "arm_group_label": "Mesalazine", 
                "arm_group_type": "Active Comparator", 
                "description": "Mesalazine 1g suppository"
            }, 
            {
                "arm_group_label": "Combination", 
                "arm_group_type": "Experimental", 
                "description": "Budesonide 2 mg suppository/Mesalazine 1 g suppository"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to investigate the efficacy and safety of budesonide\n      suppository for the treatment of acute ulcerative proctitis."
        }, 
        "brief_title": "Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative Proctitis", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Proctitis", 
        "condition_browse": {
            "mesh_term": [
                "Proctitis", 
                "Colitis, Ulcerative"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Active ulcerative proctitis\n\n          -  Diagnosis confirmed by endoscopy\n\n          -  Established disease or new diagnosis\n\n        Exclusion Criteria:\n\n          -  Crohn's disease, indeterminate colitis, ischemic colitis, radiation colitis,\n             diverticular assoc. colitis, microscopic colitis\n\n          -  Presence of proctitis of a different origin\n\n          -  Prior bowel resection\n\n          -  Presence of symptomatic organic disease of the gastrointestinal tract\n\n          -  Asthma, tuberculosis, cardiovascular disease, diabetes mellitus, osteoporosis, active\n             peptic ulcer disease, glaucoma, cataract, infection if careful medical monitoring is\n             not ensured\n\n          -  Local intestinal infection\n\n          -  Abnormal hepatic or renal function\n\n          -  Oral/rectal/intravenous corticosteroids therapy\n\n          -  Existing or intended pregnancy or breast-feeding\n\n          -  Participation in another clinical trial within the last 30 days, simultaneous\n             participation in another clinical trial, or previous participation in this trial"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "320", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01966783", 
            "org_study_id": "BUS-2/UCA", 
            "secondary_id": "2012-003362-41"
        }, 
        "intervention": [
            {
                "arm_group_label": "Budesonide dosage 1", 
                "description": "per day", 
                "intervention_name": "Budesonide 2 mg suppository", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Budesonide dosage 2", 
                "description": "per day", 
                "intervention_name": "Budesonide 4 mg suppository", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Mesalazine", 
                "description": "per day", 
                "intervention_name": "Mesalazine 1 g suppository", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Combination", 
                "description": "per day", 
                "intervention_name": "Budesonide 2 mg suppository/Mesalazine 1 g suppository", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Budesonide", 
                "Mesalamine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 14, 2014", 
        "location": [
            {
                "contact": {
                    "email": "britta.siegmund@charite.de", 
                    "last_name": "Britta Siegmund, Professor", 
                    "phone": "++40 30 450514", 
                    "phone_ext": "322"
                }, 
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "12203"
                    }, 
                    "name": "Charit\u00e9-Campus Benjamin Franklin Universit\u00e4tsmedizin Berlin"
                }, 
                "investigator": {
                    "last_name": "Britta Siegmund, Professor", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "kruis@evkk.de", 
                    "last_name": "Wolfgang Kruis, Professor", 
                    "phone": "++49 221 8289", 
                    "phone_ext": "5289"
                }, 
                "facility": {
                    "address": {
                        "city": "Cologne", 
                        "country": "Germany", 
                        "zip": "51103"
                    }, 
                    "name": "Evang. Krankenhaus Kalk, Medical Department"
                }, 
                "investigator": {
                    "last_name": "Wolfgang Kruis, Professor", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "4", 
        "official_title": "Randomized, Double-blind, Multicentre Study to Compare the Efficacy and Safety of Budesonide Versus Mesalazine Suppository Versus a Combination Therapy of Budesonide/Mesalazine Suppositories in Patients With Acute Ulcerative Proctitis", 
        "overall_contact": {
            "email": "mohrbacher@drfalkpharma.de", 
            "last_name": "Ralf Mohrbacher, MSc", 
            "phone": "++49-761-1514-0", 
            "phone_ext": "156"
        }, 
        "overall_contact_backup": {
            "email": "greinwald@drfalkpharma.de", 
            "last_name": "Roland Greinwald, PhD", 
            "phone": "++49-761-1514-0", 
            "phone_ext": "0"
        }, 
        "overall_official": [
            {
                "affiliation": "Evang. Krankenhaus Kalk, Medical Department", 
                "last_name": "Wolfgang Kruis, Professor", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Charit\u00e9-Campus Benjamin Franklin Universit\u00e4tsmedizin Berlin", 
                "last_name": "Britta Siegmund, Professor", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Symptoms as reported in the diary", 
            "measure": "Resolution of clinical symptoms", 
            "safety_issue": "No", 
            "time_frame": "8 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01966783"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Symptoms as reported in the diary, ulcerative colitis-disease activity index", 
                "measure": "Rate of clinical and endoscopic remission", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Symptoms as reported in the diary, ulcerative colitis-disease activity index", 
                "measure": "Rate of improvement", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Symptoms as reported in the diary, ulcerative colitis-disease activity index", 
                "measure": "Rate of patients with clinical remission", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Ulcerative colitis-disease activity index", 
                "measure": "Rate of patients with endoscopic remission", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }
        ], 
        "source": "Dr. Falk Pharma GmbH", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dr. Falk Pharma GmbH", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}